Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11

IF 27.7 1区生物学 Q1 CELL BIOLOGY

Cell metabolism Pub Date : 2024-08-14 DOI:10.1016/j.cmet.2024.07.014

引用次数: 0

Abstract

Nonalcoholic fatty liver disease (NAFLD), including its more severe manifestation nonalcoholic steatohepatitis (NASH), is a global public health chall…

查看原文本刊更多论文

通过抑制去泛素化酶 RPN11 改善非酒精性脂肪肝的病情

非酒精性脂肪肝（NAFLD），包括其更严重的表现形式非酒精性脂肪性肝炎（NASH），是一项全球性的公共卫生挑战。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell metabolism 生物-内分泌学与代谢

CiteScore

48.60

自引率

1.40%

发文量

173

审稿时长

2.5 months

期刊介绍： Cell Metabolism is a top research journal established in 2005 that focuses on publishing original and impactful papers in the field of metabolic research.It covers a wide range of topics including diabetes, obesity, cardiovascular biology, aging and stress responses, circadian biology, and many others. Cell Metabolism aims to contribute to the advancement of metabolic research by providing a platform for the publication and dissemination of high-quality research and thought-provoking articles.